Detalhe da pesquisa
1.
HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up.
J Viral Hepat
; 24(12): 1107-1113, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632898
2.
HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy.
J Viral Hepat
; 23(8): 652-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26945896
3.
Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life.
J Viral Hepat
; 23(12): 950-954, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27405785
4.
Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.
Haemophilia
; 22(5): 692-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339614
5.
Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up.
J Viral Hepat
; 20(4): e78-81, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23490393
6.
Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor.
J Viral Hepat
; 20(11): 779-89, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24168257
7.
First-in-human study of the pharmacokinetics and antiviral activity of IDX375, a novel nonnucleoside hepatitis C virus polymerase inhibitor.
Antimicrob Agents Chemother
; 56(8): 4525-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22664976
8.
Establishment of the first international repository for transfusion-relevant bacteria reference strains: ISBT working party transfusion-transmitted infectious diseases (WP-TTID), subgroup on bacteria.
Vox Sang
; 102(1): 22-31, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21732948
9.
Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.
Scand J Gastroenterol
; 47(4): 475-81, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22263608
10.
New developments in antiviral therapy for chronic hepatitis B.
Vox Sang
; 98(4): 481-94, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19951307
11.
Monitoring and treatment of anti-D in pregnancy.
Vox Sang
; 99(2): 177-92, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20331536
12.
Inventory management.
Vox Sang
; 98(3 Pt 1): e295-363, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20432515
13.
Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.
J Med Virol
; 81(3): 413-6, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19152408
14.
Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
J Med Virol
; 81(6): 988-95, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19382261
15.
New developments in the antiviral treatment of hepatitis C.
Vox Sang
; 97(1): 1-12, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19392783
16.
Should DEHP be eliminated in blood bags?
Vox Sang
; 106(2): 176-95, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24330039
17.
Bacterial contamination in platelet concentrates.
Vox Sang
; 106(3): 256-83, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24654780
18.
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care.
Vox Sang
; 107(3): 276-311, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24801438
19.
Donor selection and release criteria of cellular therapy products.
Vox Sang
; 104(1): 67-91, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23252690
20.
The use of the electronic (computer) cross-match.
Vox Sang
; 104(4): 350-64, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23409706